RXRX peer analysis
Recursion (RXRX) against its competitors: price, today's move, 1-year return and market value side by side.
RXRX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| DNLI Denali Therapeutics | $20.16 | 2.23% | 34.72% | $3.21B |
| MAZE Maze Therapeutics | $34.69 | 6.64% | 13.05% | – |
| RLAY Relay Therapeutics | $18.88 | 11.06% | 183.97% | – |
| RXRX Recursion | $3.53 | 0.79% | -29.03% | – |
- RXRX's peers: DNLI (Denali Therapeutics), MAZE (Maze Therapeutics), RLAY (Relay Therapeutics).
Updated 2026-11-07 11:56 UTC